Cell culture-derived influenza vaccine (AbbVie)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCell culture-derived influenza vaccine (AbbVie)

Drug Alias NameInfluvac TC US细胞培养衍生流行性感冒病毒亚单位疫苗 - 艾伯维Influvac TC EUInfluvac TC

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSolvay

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSolvay Sa Abbvie Inc

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A